Profile data is unavailable for this security.
About the company
Fidson Healthcare Plc is a Nigeria-based pharmaceutical manufacturing company. The principal activities of the Company include manufacturing and distribution of pharmaceutical products. The Company's segments include over-the-counter, ethical products, and consumer healthcare. The over-the-counter segment represents the products that may be sold directly to the consumer without a prescription. The ethical products segment represents drugs, injectables and infusions, which will be sold to the consumer only on the possession of a valid prescription. The consumer segment represents manufacturing products for customers. It provides services, including formulation/development, contract manufacturing, and production of medicines. Its products include Anti-Infective and Anti-Malaria, Central Nervous System, Gastrointestinal Medicines, Topical/Dermatological Medicines, Vitamins and Minerals, Ophthalmic Solution, among others. Its Ophthalmic Solution helps manage and treat eye conditions.
- Revenue in NGN (TTM)60.53bn
- Net income in NGN3.28bn
- Incorporated1995
- Employees650.00
- LocationFidson Healthcare PLC268, Ikorodu Road, ShomoluP.O.Box 7210LAGOS NigeriaNGA
- Phone+234 3429102
- Fax+234 3429106
- Websitehttps://www.fidson.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BioMaxima SA | 20.77bn | 154.06m | 28.45bn | 115.00 | 183.03 | 1.42 | 21.38 | 1.37 | 0.0869 | 0.0869 | 11.68 | 11.22 | 0.6653 | 1.88 | 4.77 | 423,217.40 | 0.4935 | 16.44 | 0.5661 | 22.44 | 48.78 | 40.72 | 0.7417 | 12.84 | 1.06 | 0.9304 | 0.214 | -- | -67.22 | 9.13 | -97.97 | -- | 0.7404 | -- |
| Devonian Health Group Inc | 11.75bn | -3.82bn | 28.57bn | 6.00 | -- | 1.78 | -- | 2.43 | -0.0216 | -0.0216 | 0.0665 | 0.09 | 0.4423 | 33.07 | 2.32 | 1,625,238.00 | -14.37 | -21.02 | -23.15 | -23.96 | 30.95 | 29.96 | -32.50 | -131.97 | 1.06 | -9.41 | 0.1406 | -- | 1.74 | -5.83 | -33.39 | -- | -- | -- |
| Oncimmune Holdings PLC | 2.63bn | -6.80bn | 28.66bn | 33.00 | -- | -- | -- | 10.90 | -0.0423 | 0.0958 | 0.0164 | -0.0172 | 0.1756 | 1.19 | 0.6917 | 36,787.88 | -45.43 | -- | -- | -- | 63.34 | -- | -258.65 | -- | 1.01 | -0.6511 | 1.32 | -- | -- | -- | -- | -- | -- | -- |
| Corline Biomedical AB | 2.82bn | -1.04bn | 28.71bn | 14.00 | -- | 2.04 | -- | 10.19 | -0.3005 | -0.3005 | 0.8165 | 4.07 | 0.1729 | -- | 4.69 | 1,349,769.00 | -6.36 | -5.71 | -7.13 | -6.24 | 141.25 | 128.60 | -36.80 | -38.46 | -- | -306.52 | 0.00 | -- | 6.28 | 74.14 | -177.67 | -- | 62.51 | -- |
| Cumberland Pharmaceuticals, Inc. | 61.94bn | -17.01bn | 28.88bn | 91.00 | -- | 0.6681 | -- | 0.4663 | -0.7328 | -0.7328 | 2.67 | 1.87 | 0.4501 | 0.8643 | 3.17 | 415,225.80 | -12.35 | -7.03 | -17.75 | -9.52 | 82.58 | 79.95 | -27.45 | -17.64 | 1.26 | -38.85 | 0.382 | -- | -5.85 | 6.15 | -12.73 | -- | -36.17 | -- |
| Marinomed Biotech AG | 12.03bn | -12.51bn | 28.92bn | 47.00 | -- | -- | -- | 2.40 | -4.46 | -4.46 | 4.28 | -7.69 | -- | -- | -- | 140,468.10 | -- | -33.46 | -- | -48.73 | 10.56 | 7.67 | -103.99 | -69.70 | 1.46 | -4.51 | 2.20 | -- | -18.56 | 14.50 | -6.21 | -- | -10.92 | -- |
| Cilo Cybin Holdings Ltd | -9.34tn | -9.34tn | 29.19bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 182.51 | -- | -- | -- |
| Immunoprecise Antibodies Ltd | 29.03bn | -33.26bn | 29.54bn | 102.00 | -- | 0.7461 | -- | 1.02 | -0.7669 | -0.7669 | 0.6771 | 0.8846 | 0.3546 | 6.12 | 6.16 | -- | -40.63 | -26.70 | -46.68 | -30.31 | 48.21 | 56.13 | -114.58 | -85.72 | 0.8189 | -134.72 | 0.3289 | -- | 18.65 | 17.54 | -2.32 | -- | 16.71 | -- |
| Vaidya Sane Ayurved Laboratories Ltd | 20.48bn | 711.21m | 30.19bn | 632.00 | 42.40 | 2.81 | 23.13 | 1.47 | 3.46 | 3.46 | 99.55 | 52.12 | 1.74 | 11.90 | 20.17 | 1,654,093.00 | 6.04 | -- | 7.39 | -- | 71.79 | -- | 3.47 | -- | 2.57 | 16.25 | 0.0683 | -- | 32.55 | -- | 49.62 | -- | -- | -- |
| Fidson Healthcare PLC | 60.53bn | 3.28bn | 30.29bn | 650.00 | 8.96 | 1.35 | 6.54 | 0.5005 | 1.47 | 1.47 | 26.92 | 9.75 | 1.09 | 2.19 | 8.92 | 93,123,760.00 | 5.92 | 7.96 | 11.61 | 13.32 | 39.41 | 43.22 | 5.42 | 8.37 | 0.6794 | 1.74 | 0.5908 | 32.58 | 30.56 | 26.73 | -13.84 | -- | 53.26 | 34.49 |
| Cyclo Therapeutics Inc | 1.86bn | -33.99bn | 30.62bn | 8.00 | -- | -- | -- | 16.50 | -0.9104 | -0.9104 | 0.0474 | -0.1785 | 0.242 | 0.4002 | 13.16 | 141,553.80 | -443.08 | -132.22 | -- | -215.17 | 91.56 | 90.37 | -1,831.29 | -1,114.04 | 0.4283 | -- | -- | -- | -21.76 | 1.25 | -29.81 | -- | -3.95 | -- |
| TherapeuticsMD Inc | 1.63bn | -7.92bn | 31.38bn | 1.00 | -- | 0.6918 | -- | 19.22 | -0.4348 | -0.5538 | 0.0889 | 2.40 | 0.0212 | -- | 0.5048 | 996,000.00 | -10.31 | -53.35 | -13.13 | -111.61 | 45.08 | 86.67 | -485.34 | -236.57 | -- | -- | 0.00 | -- | -98.14 | -39.53 | -816.85 | -- | -- | -- |
